E. Picano et al., COMBINED LOW-DOSE DIPYRIDAMOLE-DOBUTAMINE STRESS ECHOCARDIOGRAPHY TO IDENTIFY MYOCARDIAL VIABILITY, Journal of the American College of Cardiology, 27(6), 1996, pp. 1422-1428
Objectives. We sought to evaluate the effects of combined administrati
on of infra-low dose dipyridamole and low dose dobutamine on assessmen
t of myocardial viability. Background. Low dose pharmacologic stress e
chocardiography with either dobutamine or dipyridamole infusion has be
en proposed for the recognition of myocardial viability. Methods. Thir
ty-four patients with rest wall motion dyssynergy by two-dimensional e
chocardiography and with angiographically proved coronary artery disea
se underwent in combination with two-dimensional echocardiographic mon
itoring: 1) low dose (5 to 10 mu g/kg per min over 3 min) dobutamine i
nfusion; 2) infra-low dose (0.28 mg/kg over 4 min) dipyridamole infusi
on; 3) combination of infra-low dose dipyridamole infusion immediately
followed by low dose dobutamine infusion (combined dipyridamole-dobut
amine). Results. Follow-up rest echocardiography was available in 30 p
atients. After revascularization, 82 segments showed a contractile imp
rovement of greater than or equal to 1 grade, whereas 63 segments rema
ined unchanged. The sensitivity of dobutamine, dipyridamole and combin
ed dipyridamole-dobutamine for predicting recovery was 72% (95% confid
ence interval [CI] 60.9% to 81.3%), 67% (CI 55.8% to 77%) and 94% (CI
86.3% to 97.9%), respectively. The specificity of dipyridamole, dobuta
mine and combined dipyridamole-dobutamine was 95% (CI 86.7% to 99%), 9
2% (CI 82.4% to 97.3%) and 89% (CI 78.4% to 95.4%), respectively. The
accuracy of the dobutamine, dipyridamole and combined dipyridamole-dob
utamine test was 80%, 79% and 92%, respectively (combined dipyridamole
-dobutamine vs, dobutamine, p < 0.05; combined dipyridamole-dobutamine
vs. dipyridamole, p < 0.01). Conclusions. Infra-low dose dipyridamole
added to low dose dobutamine recruits an inotropic reserve in asynerg
ic segments that were nonresponders after either dobutamine or dipyrid
amole alone and destined to recover after revascularization.